Mr. Budhoo et al., THE ROLE OF THE 5-HT4 RECEPTOR IN CL- SECRETION IN HUMAN JEJUNAL MUCOSA, European journal of pharmacology, 314(1-2), 1996, pp. 109-114
5-Hydroxytryptamine (5-HT) is a mediator of chloride ion (Cl-) secreti
on in the intestine which can be seen as a rise in short circuit curre
nt (I-sc) in the Ussing chamber model. We investigated the 5-HT recept
or mediating 5-HT-induced Cl- secretion in the human jejunum in vitro.
Jejunal segments obtained from patients having gastric bypass surgery
for obesity, were stripped of muscularis and mounted in Ussing chambe
rs and short-circuited. The 5-HT receptor agonist-induced change (Delt
a) in I-sc was recorded in the presence and absence of 5-HT receptor a
ntagonists. The rank order of agonist potency was: 5-HT > 5-methoxytry
ptamine > renzapride (BRL 24924) > alpha-methyl-5-HT > > 2-methyl-5-HT
. In the presence of Cl--free media or 100 mu M furosemide, 5-HT-induc
ed Delta I-sc was significantly reduced. It was also antagonized by gr
eater than or equal to 1 mu M tropisetron (a 5-HT3/5-HT4 receptor anta
gonist) and greater than or equal to 10 nM GR 113808 (a selective 5-HT
4 receptor antagonist) with pA(2) values of 6.5 and 7.9, respectively.
Another 5-HT4 receptor antagonist, SC 53606 (0.1 mu M), antagonized t
he 5-HT-induced response with a pA(2) of 7.3. 5-HT1-like/5-HT2 (methys
ergide), 5-HT1P [N-acetyl-5-hydroxytryptophyl 5-hydroxytryptophan amid
e (5-HTP-DP)], 5-HT2A (ketanserin) and 5-HT3 (ondansetron) receptor an
tagonists and tetrodotoxin, had no significant effect bn the EC(50) fo
r 5-HT. In conclusion, this study demonstrates that in the human muscl
e-stripped jejunum in vitro, 5-HT induced change in short circuit curr
ent is mediated by a 5-HT4 receptor via a non-neural pathway.